EDITO

We are pleased to introduce you to the 1st edition of the Pulmonary Clinical Trials (PCT) Workshop, which will take place on June 5-7, 2026 in Washington, D.C.

PCT 2026 is where the brightest minds in pulmonary clinical research, and the healthcare industry come together to shape the future of pulmonary medicine. Our mission is to foster collaboration, spark innovation, and enhance clinical trial design to better serve the global pulmonary medicine community.

The PCT Workshop aims to foster an international exchange of ideas where we will engage in candid discussion on trial design, conduct, ethics, interpretation, approvability and implementation encompassing drugs, devices, biomarkers and therapeutic strategies for pulmonary medicine.

This new edition will gather an exceptional expert faculty of distinguished pulmonologists, immunologists, intensivists, patients, clinical trialists, principal investigators and statisticians from academia, R&D pharma and device companies, medical journals, regulators, and FDA experts, who will meet to discuss and brainstorm on trial design, conduct, ethics, interpretation, approvability and implementation encompassing drugs, devices, biomarkers and therapeutic strategies for pulmonary medicine.

We invite once again our industry partners to join this vital workshop, where their scientific expertise and financial support are crucial in advancing innovative kidney disease trials that will shape the future of patient care and treatment outcomes.

Vincent Cottin and Marc Humbert

Workshop Directors